Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers

Garlic (Allium sativum L.) is a commonly used food and herbal supplement. The objective of this study was to assess in healthy volunteers (N = 14) the influence of a garlic extract on the activity of cytochrome P450 (CYP) 2D6 and 3A4. Probe substrates dextromethorphan (CYP2D6) and alprazolam (CYP3A4) were administered orally at baseline and again after treatment with garlic extract (3 × 600 mg twice daily) for 14 days. Urinary dextromethorphan/dextrorphan ratios and alprazolam plasma concentrations were determined by HPLC at baseline and after garlic extract treatment. The ratio of dextromethorphan to its metabolite was 0.044 ± 0.48 at baseline and 0.052 ± 0.095 after garlic supplementation. There were no significant differences between the baseline and garlic phases (P ≥ .05). For alprazolam, there were no significant differences in pharmacokinetic parameters at baseline and after garlic extract treatment (all P values ≥ .05; maximum concentration in plasma, 27.3 ± 2.6 ng/mL versus 27.3 ± 4.8 ng/mL; time to reach maximum concentration in plasma, 1.9 ± 1.4 h versus 2.4 ± 1.8 h; area under the time‐versus‐concentration curve, 537 ± 94 h · ng · mL−1 versus 548 ± 159 h · ng · mL−1; half‐life of elimination, 13.7 ± 4.4 h versus 14.5 ± 4.3 h). Our results indicate that garlic extracts are unlikely to alter the disposition of coadministered medications primarily dependent on the CYP2D6 or CYP3A4 pathway of metabolism.

[1]  René H. Levy,et al.  Metabolic Drug Interactions , 2000 .

[2]  I. Pastan,et al.  HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. , 1998, Biochemistry.

[3]  D J Greenblatt,et al.  Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes. , 1999, Biochemical pharmacology.

[4]  A. Fugh-Berman,et al.  Herb-drug interactions: review and assessment of report reliability. , 2001, British journal of clinical pharmacology.

[5]  K. Brøsen Drug-metabolizing enzymes and therapeutic drug monitoring in psychiatry. , 1996, Therapeutic drug monitoring.

[6]  David J. Greenblatt,et al.  Clinical Pharmacokinetics of Alprazolam , 1993, Clinical pharmacokinetics.

[7]  M. Gershwin,et al.  Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. , 1999, Life Science.

[8]  C. DeVane,et al.  Alprazolam, alpha-hydroxy- and 4-hydroxyalprazolam analysis in plasma by high-performance liquid chromatography. , 1988, Journal of chromatography.

[9]  R. Kessler,et al.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. , 1998, JAMA.

[10]  D. Papadimitriou,et al.  Allicin Release under Simulated Gastrointestinal Conditions from Garlic Powder Tablets Employed in Clinical Trials on Serum Cholesterol , 2001, Planta medica.

[11]  J. Bircher,et al.  Polymorphic dextromethorphan metabolism: Co‐segregation of oxidative O‐demethylation with debrisoquin hydroxylation , 1985, Clinical pharmacology and therapeutics.

[12]  B. McCrindle,et al.  Garlic extract therapy in children with hypercholesterolemia. , 1998, Archives of pediatrics & adolescent medicine.

[13]  S J Ziegler,et al.  HPLC of S-Alk(en)yl-L-cysteine Derivatives in Garlic including Quantitative Determination of (+)-S-Allyl-L-cysteine Sulfoxide (Alliin) , 1989, Planta medica.

[14]  S. Gardner,et al.  Cytochrome P450 phenotypic ratios for predicting herb‐drug interactions in humans , 2002, Clinical pharmacology and therapeutics.

[15]  K. Gallicano,et al.  An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. , 2001, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[16]  D. Greenblatt,et al.  Alprazolam is another substrate for human cytochrome P450-3A isoforms. , 1998, Journal of clinical psychopharmacology.

[17]  J. Donovan,et al.  Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[18]  E. Block The chemistry of garlic and onions. , 1985, Scientific American.

[19]  L. D. Lawson,et al.  Low allicin release from garlic supplements: a major problem due to the sensitivities of alliinase activity. , 2001, Journal of agricultural and food chemistry.

[20]  J. Falloon,et al.  The effect of garlic supplements on the pharmacokinetics of saquinavir. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  K. Gallicano,et al.  Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. , 2003, British journal of clinical pharmacology.

[22]  G. Shenfield,et al.  Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[23]  M. Harkey,et al.  Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. , 1999, Life sciences.

[24]  H. Miething HPLC‐analysis of the volatile oil of garlic bulbs , 1988 .

[25]  Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeine. , 1999, Pharmacogenetics.

[26]  C. DeVane,et al.  Alprazolam, α-hydroxy- and 4-hydroxyalprazolam analysis in plasma by high-performance liquid chromatography , 1988 .

[27]  P. N. Kaul,et al.  Alternative medicine: Herbal drugs nd their critical appraisal - Part I , 2001 .

[28]  H. Black,et al.  Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. , 1998, Archives of internal medicine.

[29]  D. Smith,et al.  Human cytochrome P450s: selectivity and measurement in vivo. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[30]  P. N. Kaul,et al.  Alternative medicine: herbal drugs and their critical appraisal--part II. , 2001, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.